REALLY, revenue up 66%, expenses up 41%, loss after tax up 27% to $9M.
They are not getting traction with KP. It’s been over a year that they have been trying to interstate. They may have a great product with clinical utility but with the first bulk order customer they can’t Integrate systems for ordering and processes?
a really disappointing result. The SP has take. A hammering as a result. The only good thing is that they won’t need to raise funds for a while.
the sales force needs to get traction otherwise why are we paying them. It would seem to me that covid is causing issues generally - sure we can do in home testing, but if people aren’t going out to the doctor it’s irrelevant.
- Forums
- NZX - By Stock
- PEB
- Latest Result
Latest Result, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add PEB (NZSX) to my watchlist
(20min delay)
|
|||||
Last
15.8¢ |
Change
0.003(1.94%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
15.6¢ | 16.4¢ | 15.6¢ | $35.83K | 223.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
0 | 12879 | 15.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.4¢ | 76943 | 0 |
Last trade - 11.00am 04/10/2024 (20 minute delay) ? |
Featured News
PEB (NZSX) Chart |